When.com Web Search

  1. Ads

    related to: winrevair fda approval date for evenity 1 gram

Search results

  1. Results From The WOW.Com Content Network
  2. US FDA approves Merck's therapy for rare lung condition - AOL

    www.aol.com/news/us-fda-approves-mercks-blood...

    Winrevair will carry a list price of $14,000 per vial, Oosthuizen said. According to data from the company's trial, most patients will use a single vial every three weeks, which would translate to ...

  3. Sotatercept - Wikipedia

    en.wikipedia.org/wiki/Sotatercept

    Sotatercept, sold under the brand name Winrevair is a medication used for the treatment of pulmonary arterial hypertension. [6] It is an activin signaling inhibitor, [ 6 ] based on the extracellular domain of the activin type 2 receptor expressed as a recombinant fusion protein with immunoglobulin Fc domain (ACTRIIA-Fc). [ 9 ]

  4. Merck's therapy for rare lung condition shown to help reduce ...

    www.aol.com/news/mercks-therapy-rare-lung...

    Winrevair, which costs around $238,000 annually, was the first treatment to secure approval from the U.S. Food and Drug Administration from a class of drugs, which target a type of protein called ...

  5. Romosozumab - Wikipedia

    en.wikipedia.org/wiki/Romosozumab

    Romosozumab, sold under the brand name Evenity (/ ɪ ˈ v ɛ n ɪ t i / ih-VENN-ih-tee or with the pin-pen merger, / ɪ ˈ v ɪ n ɪ t i / ih-VINN-ih-tee), is a medication used to treat osteoporosis. [7] [8] It has been found to decrease the risk of fractures of the spine. [7] Common side effects include headache, joint pain, and injection site ...

  6. Where Will Merck Be in 5 Years? - AOL

    www.aol.com/where-merck-5-years-211100190.html

    The company recently earned approval for Winrevair, a therapy for pulmonary arterial hypertension with a new mechanism of action. According to some analysts, Winrevair could hit sales of $3.9 ...

  7. List of drugs granted breakthrough therapy designation

    en.wikipedia.org/wiki/List_of_drugs_granted...

    To treat desmoid tumors [1] Pombiliti: To treat late-onset Pompe disease with miglustat [1] Rivfloza: To lower urinary oxalate levels in primary hyperoxaluria type 1 and relatively preserved kidney function [1] Talvey: To treat relapsed or refractory multiple myeloma after at least four therapies [1]

  1. Ads

    related to: winrevair fda approval date for evenity 1 gram